title: Atezolizumab-induced Encephalitis in Metastatic Bladder Cancer: A Case Report and Review of the Literature.
authors.affiliation: Department of Hematology and Oncology, MD Anderson Cancer Center at Cooper University Hospital, Camden, NJ. Electronic address: levine-jeffrey@cooperhealth.edu.
authors.forename: Jeffrey J
authors.initials: JJ
authors.lastname: Levine
authors.affiliation: Department of Hematology and Oncology, MD Anderson Cancer Center at Cooper University Hospital, Camden, NJ.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Somer
authors.affiliation: Department of Internal Medicine, Pennsylvania Hospital of the University of Pennsylvania, Philadelphia, PA.
authors.forename: Hitomi
authors.initials: H
authors.lastname: Hosoya
authors.affiliation: Department of Hematology and Oncology, MD Anderson Cancer Center at Cooper University Hospital, Camden, NJ.
authors.forename: Christian
authors.initials: C
authors.lastname: Squillante
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D004660:Encephalitis / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D013256:Steroids / Q000627:therapeutic use; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D013256:Steroids; C000594389:atezolizumab
keywords: Altered mental status; Immune check point inhibitor; Immunotherapy; PD-L1 inhibitor; Urothelial cell carcinoma